What is Neurocrine Biosciences's income tax?

Neurocrine Biosciences (NBIX) reported income tax of $48.9M in Q1 2026.

How has Neurocrine Biosciences's income tax changed year-over-year?

Neurocrine Biosciences's income tax increased by 619.1% year-over-year, from $6.8M to $48.9M.

What is the long-term trend for Neurocrine Biosciences's income tax?

Over 3 years (2022 to 2025), Neurocrine Biosciences's income tax has grown at a 56.3% compound annual growth rate (CAGR), from $59.4M to $226.8M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Neurocrine Biosciences NBIX Income Tax

Income Tax at other companies

Bristol-Myers SquibbBMY

$561M+10.2%

Acadia PharmaceuticalsACAD

$344K-96.1%

CRN

CRNXCRNX

$45K—

BiogenBIIB

$58.2M-17.7%

Rhythm Pharmaceuticals, Inc.RYTM

$545K+581%

Ionis PharmaceuticalsIONS

$218K+87.9%

Segments

By segment

See full

Reportable Segment$48.9M+619%

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$17.3B+29.6%

Enterprise value$17.49B+28.9%

P/E25.9×-12.5×

P/S5.6×+0.3×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's income tax?: Neurocrine Biosciences (NBIX) reported income tax of $48.9M in Q1 2026.
How has Neurocrine Biosciences's income tax changed year-over-year?: Neurocrine Biosciences's income tax increased by 619.1% year-over-year, from $6.8M to $48.9M.
What is the long-term trend for Neurocrine Biosciences's income tax?: Over 3 years (2022 to 2025), Neurocrine Biosciences's income tax has grown at a 56.3% compound annual growth rate (CAGR), from $59.4M to $226.8M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.